Wire Stories
565China Anastrozole Market Report 2021: Sales 2016-2020, Major Manufacturers, Prices 2020-2021, Prospects 2021-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Anastrozole Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Anastrozole was developed by AstraZeneca with...
- 488
China Anastrozole Market Report 2021: Sales 2016-2020, Major Manufacturers, Prices 2020-2021, Prospects 2021-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Anastrozole Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Anastrozole was developed by AstraZeneca with...
- 523
China Nicorandil Market Research Report 2021: Sales 2016-2020, Major Manufacturers, Prices 2020-2021, Prospects 2021-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Nicorandil Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. The rising number of patients with...
- 447
China Dabigatran Etexilate Market Research Report 2021: Sales 2016-2020, Major Manufacturers, Prices 2020-2021, Prospects 2021-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Dabigatran Etexilate Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Dabigatran Etexilate is an oral...
- 638
Sumitomo Corporation Quantum Transformation (QX) Project Will Exhibit Online at SXSW2022
– Quantum Transformation, The Next Paradigm Shift. – TOKYO–(BUSINESS WIRE)–#QX–Sumitomo Corporation’s Quantum Transformation (QX) Project will present at the South by Southwest...
- 557
China Dabigatran Etexilate Market Research Report 2021: Sales 2016-2020, Major Manufacturers, Prices 2020-2021, Prospects 2021-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Dabigatran Etexilate Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Dabigatran Etexilate is an oral...
- 492
Research Report on China’s Levetiracetam Market, 2016-220 & 2021-2025: A First-Line Drug in the Field of Epilepsy Treatment, First Developed by UCB Under the Trade Name of Keppra – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Levetiracetam Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Levetiracetam was first developed by UCB...
- 503
Research Report on China’s Levetiracetam Market, 2016-220 & 2021-2025: A First-Line Drug in the Field of Epilepsy Treatment, First Developed by UCB Under the Trade Name of Keppra – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Levetiracetam Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Levetiracetam was first developed by UCB...
- 529
Research Report on China’s Alectinib Markets, 2016-2020 & 2021-2025: Originally Developed by Roche for Patients with the Zotinib-Resistant ALK-Positive Non-Small Cell Lung Cancer – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Alectinib Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Alectinib, originally developed by Roche, was...
- 522
Research Report on China’s Gefitinib Markets, 2016-2020 & 2021-2025: The World’s First Marketed EGFR-TKI, Originally Developed by AstraZeneca – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Gefitinib Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Gefitinib, originally developed by AstraZeneca, is...
